Bibliometric Analysis of Global Scientific Production on COVID-19 and Vaccines
Antônio Rosa de Sousa Neto, Ana Raquel Batista de Carvalho, Márcia Daiane Ferreira da Silva, Marly Marques Rêgo Neta, Inara Viviane de Oliveira Sena, Rosângela Nunes Almeida, Francidalma Soares Sousa Carvalho Filha, Laianny Luize Lima e Silva, Girlene Ribeiro da Costa, Ivana Mayra da Silva Lira, Denise Maria Meneses Cury Portela, Amanda Tauana Oliveira e Silva, Cristiane Borges de Moura Rabêlo, Andréia Rodrigues Moura da Costa Valle, Maria Eliete Batista Moura, Daniela Reis Joaquim de Freitas
Abstract
This bibliometric analysis aims to analyze the global scientific production of COVID-19 and vaccines. First, a search for scientific articles was performed using the advanced query in the Web of Science™ database, more precisely in its core collection, on 18 February 2023. Data from 7754 articles were analyzed using the Bibliometrix R package and the Biblioshiny application. The evaluated articles were published mainly in 2022 (60%). The scientific journals that published the most about COVID-19 and vaccines were "Vaccines", "Vaccine" and "Human Vaccines & Immunotherapeutics". The University of Oxford was the most productive institution, with the authors of the articles mainly originating from the United States, China and the United Kingdom. The United States, despite having carried out the most significant number of collaborations, published mainly with local researchers. The 15 most cited articles and the KeyWords Plus™ evidenced the focus of the published articles on the safety and efficacy of vaccines against COVID-19, as well as on the evaluation of vaccine acceptance, more specifically on vaccine hesitancy. Research funding came primarily from US government agencies.